← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Scotts Miracle-Gro improved profit and margin despite lower revenue, but weaker cash conversion and elevated inventory kept the recovery incomplete.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 3.9%Watch
- Profitability — The company moved from a net loss of $34.9M to net income of $145.2MOK
- Cash flow — Free cash flow declined 53.1% to $273.9M from $583.5MWatch
- Margins — Operating margin expanded 463 bps to 10.51%OK
- Accounting — Margin recovery with softer cash conversionNote
- Insiders — 2 purchases and 3 salesOK
Business
Scotts Miracle-Gro markets lawn, garden and hydroponic products.
Where the revenue comes from
Fiscal 2025, as SCOTTS MIRACLE-GRO CO reports it. History and quarterly detail are in the app.
- U.S. Consumer$3.0B
- Other non-reportable operating$253.6M
- Hawthorne$165.8M
Leadership changes
From SCOTTS MIRACLE-GRO CO's own filings, the day they're filed.
- John R. Vines · member · departureeff. 2025-07-31
- Nick Miaritis · director · departureeff. 2025-01-31
- Tom Kelly · member · departureeff. 2025-01-27
Latest filings
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-08-27
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about SCOTTS MIRACLE-GRO CO, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.